Jaguar Health
JAGX
5 hedge funds and large institutions have $35.2K invested in Jaguar Health in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, reducing their positions, and 0 closing their positions.
43% more capital invested
Capital invested by funds: $24.6K → $35.2K (+$10.6K)
25% more funds holding
Funds holding: 4 → 5 (+1)
0.01% more ownership
Funds ownership: 0.03% → 0.03% (+0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$39.2K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$9.12K |
| 3 |
SS
SBI Securities
Tokyo,
Japan
|
+$912 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DB
Danske Bank
Copenhagen K,
Denmark
|
-$10 |
JAGX Hedge Fund Activity: Q2 2025 in Review
5 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Jaguar Health (JAGX) for Q2 2025, worth a combined $35.2K — up 43% from $24.6K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new JAGX positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $39.2K. The largest seller was Danske Bank, cutting an estimated $10.
- 5 institutional investors held Jaguar Health (JAGX) as of Q2 2025, up from 4 in Q1 2025.
- Funds reported $35.2K of Jaguar Health stock for Q2 2025, up 43% quarter-over-quarter.
- 1 fund opened new Jaguar Health positions in Q2 2025 and 0 closed out, a net change of +1 holder.
- The largest Jaguar Health buyer in Q2 2025 was UBS Group, an estimated $39.2K added.
- The largest Jaguar Health seller in Q2 2025 was Danske Bank, an estimated $10 sold.
Based on aggregated 13F filings for Q2 2025.